Label Image (Lbl500905169)
Prasugrel
Product Images NDC 50090-5169
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 50090-5169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Prasugrel Fig1)
This text is a chart with data related to bleeding events in patients taking Prasugrel and Clopidogrel. There is not enough context to provide further information.*
Figure 2 (Prasugrel Fig2)
Figure 3 (Prasugrel Fig3)
The text describes a graph or chart showing the percentage of cardiovascular death, nonfatal MI (heart attack), or nonfatal stroke for patients with UA/NSTEMI over a period of 450 days from randomization. Two different treatments, Clopidogrel and Prasugrel, are compared on this chart. There is no other available information in the text.*
Figure 3 (Prasugrel Fig4)
This is a chart that shows the percentage of cardiovascular death, nonfatal MI, or nonfatal stroke over time (in days) from randomization for the medications Clopidogrel and Prasugrel. The percentages are not provided in the text.*
Figure 4 (Prasugrel Fig5)
This is a description of the Baseline Characteristics of a study, presumably related to cardiology. The document lists several categories such as age, body weight, metabolic syndrome, and previous medical history. The study also involves stent type and P II inhibitor use among participants. There is information regarding events and percentages related to the use of Prasugrel and Clopidogrel. The document concludes with a statement on the Hazard Ratio, suggesting that Prasugrel is better than Clopidogrel.*
Figure 5 (Prasugrel Fig6)
This is a table of the characteristics and medical history of patients from different regions who have had a stent placed. It includes information on gender, body weight, diabetes, heart attacks, previous procedures, medications, and stent types. There are also percentages of adverse events experienced by patients who took either Clopidogrel or Prasugrel.*
Structural Formula (Prasugrel Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
